Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

National Screening i Danmark Med MR-scanning af Brystet Kontra Klinisk Mammografi Hos Kvinder Der er bærere af Risikogivende BRCA1 Eller BRCA2 Mutationer

NCT00413491 is registered in ClinicalTrials.gov with Danish Breast Cancer Cooperative Group as lead sponsor.

NCT NCT00413491
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00413491 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
National Screening i Danmark Med MR-scanning af Brystet Kontra Klinisk Mammografi Hos Kvinder Der er bærere af Risikogivende BRCA1 Eller BRCA2 Mutationer
Lead sponsor
Danish Breast Cancer Cooperative Group
Phase
Phase 4
Overall status
Unknown status
Start date
January 31, 2007
Completion date
June 30, 2015
Enrollment
300 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer